tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
Australian Market

Clinuvel Pharmaceuticals (CUV) Financial Statements

Compare
99 Followers

Clinuvel Pharmaceuticals Financial Overview

Clinuvel Pharmaceuticals 's market cap is currently AU$552.21M. The company's EPS TTM is AU$0.439; its P/E ratio is 15.57; and it has a dividend yield of 0.38%. Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 95.02MAU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98M
Gross ProfitAU$ 79.14MAU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20M
Operating IncomeAU$ 45.73MAU$ 48.01MAU$ 40.91MAU$ 33.08MAU$ 26.70M
EBITDAAU$ 57.20MAU$ 56.28MAU$ 46.37MAU$ 35.08MAU$ 28.19M
Net IncomeAU$ 36.17MAU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 224.11MAU$ 183.87MAU$ 156.81MAU$ 121.51MAU$ 82.69M
Total AssetsAU$ 271.75MAU$ 231.12MAU$ 194.52MAU$ 144.81MAU$ 108.57M
Total DebtAU$ 528.53KAU$ 879.78KAU$ 999.87KAU$ 1.26MAU$ 1.30M
Net DebtAU$ -223.58MAU$ -182.99MAU$ -22.87MAU$ -26.15MAU$ -35.84M
Total LiabilitiesAU$ 30.94MAU$ 28.11MAU$ 29.89MAU$ 19.25MAU$ 9.83M
Stockholders' EquityAU$ 240.81MAU$ 203.01MAU$ 164.63MAU$ 125.56MAU$ 98.74M
Cash Flow
Free Cash FlowAU$ 40.80MAU$ 31.48MAU$ 35.88MAU$ 39.44MAU$ 18.41M
Operating Cash FlowAU$ 41.10MAU$ 37.05MAU$ 36.91MAU$ 39.87MAU$ 19.26M
Investing Cash FlowAU$ -47.72MAU$ -29.03MAU$ -1.03MAU$ -434.44KAU$ -854.33K
Financing Cash FlowAU$ -2.94MAU$ -3.57MAU$ -2.24MAU$ -1.50MAU$ -1.48M
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History

Clinuvel Pharmaceuticals Debt to Assets

Clinuvel Pharmaceuticals Cash Flow

Clinuvel Pharmaceuticals Forecast EPS vs Actual EPS